Prostate Health Archive

Prostate cancer can progress over long durations, and if a man's tumor has features that predict slow growth, he can opt for active surveillance instead of immediate treatment. But when the time for treatment comes, up to a third of men still decide against it. Now, a new study finds that for some of these men, treatment can be safely delayed.

The FDA has approved a new medication therapy for advanced prostate cancer that is spreading in the body. The new treatment can seek out and destroy tumors that are still too small to be found via conventional medical imaging. Results of a clinical trial showed that this new drug was effective at delaying cancer progression.

Today, most surgeries to remove the prostate gland in men with prostate cancer are performed with robotic assistance, which ostensibly offers quality-of-life advantages. But how does this method compare with traditional open surgery? A recent study provides some clarity.

Many men have questions regarding the testing and screening processes for prostate cancer, such as whether prostate-specific antigen tests are still the standard, when it is time for a biopsy, and what new technologies are available to help with a more accurate diagnosis. Harvard Medical School prostate cancer expert Dr. Marc Garnick provides the answers.

Prostatitis is a common inflammatory condition, but most cases have no obvious cause. Treatments are varied and include anti-inflammatory painkillers and alpha blockers, but a clinical trial showed that acupuncture has the potential to reduce symptoms of prostatitis without the side effects that drugs can cause.

In the United States, screening tests for prostate cancer are mostly done as biopsies through the rectum, but this procedure comes with a risk of infection. Technical advances are making it possible for doctors to perform a different kind of biopsy procedure in their offices, and a recent study compared the two types.